Reduced nephron number and glomerulomegaly in Australian Aborigines: A group at high risk for renal disease and hypertension

Kidney International

Volumn 70, Issue 1, 2006, Pages 104-110

  Hoy, W E ^a   Hughson, M D ^b   Singh, G R ^c   Douglas Denton, R ^d   Bertram, J F ^d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Australian Aborigines; Glomerular number; Hypertension; Renal disease

Indexed keywords

ABORIGINE; ADULT; ARTICLE; AUTOPSY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; FEMALE; FETUS GROWTH; GENETIC SUSCEPTIBILITY; GLOMERULOMEGALY; GLOMERULOPATHY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY INJURY; MALE; NEPHRON; PRIORITY JOURNAL;

ADULT; AUSTRALIA; BODY HEIGHT; BODY MASS INDEX; BODY SURFACE AREA; BODY WEIGHT; DISEASE SUSCEPTIBILITY; HUMANS; HYPERTENSION, RENAL; KIDNEY FAILURE; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; NEPHRONS; OCEANIC ANCESTRY GROUP; ORGAN SIZE;

EID: 33745711909     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000397     Document Type: Article

References (55)

1. Spencer JS, Silva D, Snelling P, Hoy WE. An epidemic of renal failure among Australian Aborigines. Med J Aust 1998; 168: 537-541.
2. McDonald SP, Russ GR. Current incidence, treatment patterns and outcome of end-stage renal disease among indigenous groups in Australia and New Zealand. Nephrology 2003; 8: 42-48.
3. Hoy WE, McDonald M. Albuminuria, marker or target in Indigenous populations. Kidney Int Suppl 2004; 92: S25-S31.
4. Hoy WE, Mathews JD, Pugsley DJ et al. The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community. Kidney Int 1998; 54: 1296-1304.
5. McDonald SM, Maguire GP, Hoy WE. Renal function and cardiovascular risk markers in a remote Australian Aboriginal community. Nephrol Dial Transplant 2003; 18: 1555-1561.
6. McDonald SM, Maguire G, Duarte N et al. C reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community. Clin Sci (London) 2004; 106: 121-128.
7. Rowley KG, Iser DM, Best JD et al. Albuminuria in Australian Aboriginal people: prevalence and associations with components of the metabolic syndrome. Diabetologia 2000; 43: 1397-1403.
8. Hoy W, Kondalsamy-Chennakesavan S, Scheppingen J, Sharma S. Kidney and related chronic disease profiles and risk factors in three remote Australian Aboriginal communities. Adv Chronic Kidney Dis 2005; 12: 64-70.
9. Hoy WE, Kondalsamy-Chennakesavan S, Scheppingen J et al. A chronic disease outreach program for Australian Aboriginal communities. Kidney Int 2005; 68: S76-S82.
10. Mortality in the Northern Territory, 1979-1997, Darwin: Territory Health Services, 1999. Enquiries to epidemiology@nt.gov.au.
11. The Health and Welfare of Australia's Aboriginal and Torres Strait Islander People, 2001. Australian Bureau of Statistics. ABS Catalogue No. 4704.0, August 2001, www.aihw.gov.au.
12. Hoy WE. Renal disease as metaphor: towards a more integrated view of Aboriginal health. The Austin Doyle Lecture: High Blood Pressure Council of Australia. Clin Exp Pharmacol Physiol 1998; 25: 1038-1042.
13. Cass A, Cunningham J, Wang Z, Hoy WE. Regional variation in the incidence of end-stage renal disease in Indigenous Australians. Med J Aust 2001; 175: 24-27.
14. Cass A, Cunningham J, Snelling P et al. End-stage renal disease in indigenous Australians: a disease of disadvantage. Ethnic Dis 2002; 12: 373-378.
15. Cass A, Cunningham J, Snelling P et al. Exploring the pathways leading from disadvantage to end-stage renal disease for Indigenous Australians. Soc Sci Med 2004; 58: 767-785.
16. Nenov VD, Taal MW, Sakharova OV, Brenner BM. Multi-hit nature of chronic renal disease. Curr Opin Nephrol Hypertens 2000; 9: 85-97.
17. Hoy WE, Kile E, Rees M, Mathews JD. Low birthweight and renal disease in Australian Aborigines. Lancet 1998; 352: 1826-1827.
18. Hoy WE, Rees M, Kile E et al. A new dimension to the Barker hypothesis: low birthweight and susceptibility to renal disease. Kidney Int 1999; 56: 1072-1077.
19. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure: less of one, more of the other? Am J Hypertens 1988; 1: 335-347.
20. Brenner BM, Mackenzie HS. Nephron mass as a risk factor for progression of renal disease. Kidney Int Suppl 1997; 63: S124-S127.
21. Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 1996; 49: 1774-1777.
22. Hoy WE, Douglas-Denton RN, Hughson M et al. A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int 2003; 63: S31-S37.
23. Hughson M, Farris III AB, Douglas-Denton R et al. Glomerular number and size in autopsy kidneys: the relationship to birthweight. Kidney Int 2003; 63: 2113-2122.
24. Keller G, Zimmer G, Mall G et al. Nephron number in patients with primary hypertension. N Engl J Med 2003; 348: 101-108.
25. Hoy WE, Hughson MD, Douglas-Denton R et al. Nephron number, hypertension, renal disease and renal failure. J Am Soc Nephrol 2005; 16: 2557-2564.
26. Hughson MD, Douglas-Denton RN, Bertram JF, Hoy WE. Hypertension, glomerular number, and birth weight in African Americans and whites in the Southeastern United States. Kidney Int 2006; 69: 671-678.
27. Singh GR, Hoy WE. Kidney volume, blood pressure, and albuminuria: findings in an Australian Aboriginal community. Am J Kidney Disease 2004; 43: 254-259.
28. Spencer JS, Wang Z, Hoy WE. Birthweight and renal volume in Aboriginal children. Is the susceptibility to renal disease associated with low birthweight mediated through impaired nephrogenesis? Am J Kidney Dis 2001; 37: 915-920.
29. Singh GR, Hoy WE. Kidney volume, blood pressure, and albuminuria: findings in an Australian aboriginal community. Am J Kidney Disease 2004; 43: 254-259.
30. Eide MG, Oyen N, Skjareven R et al. Size at birth and gestational age as predictors of adult health and weight. Epidemiology 2005; 16: 1750181.
31. Samuel T, Douglas-Denton R, Bertram JF et al. Determinants of individual glomerular volume in the human kidney. J Am Soc Nephrol 2005; 16: 3102-3109.
32. Hinchliffe SA, Sargent PH, Howard CV et al. Human intrauterine renal growth expressed in absolute number of glomeruli assessed by the disector method and Cavalieri principle. Lab Invest 1991; 64: 777-784.
33. Hinchliffe SA, Lynch MRJ, Sargent PH et al. The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol 1992; 99: 296-301.
34. Merlet Benichou C. Influence of the fetal environment on kidney development. Int J Dev Biol 1999; 43: 453-456.
35. Merlet-Benichou C, Vilar J, Lelievre-Pegorier M et al. Fetal nephron mass, its control and deficit. Advanc Nephrol 1997; 26: 19-45.
36. Lelievre-Pegorier M, Merlet-Benichou C. The number of nephrons in the mammalian kidney: environmental influences play a determining role. Exp Nephrol 2000; 8: 63-65.
37. Lampl M, Kuzawa CW, Jeanty P. Infants thinner at birth exhibit smaller kidneys for their size in late gestation in a sample of fetuses with appropriate growth. Am J Hum Biol 2002; 14: 398-406.
38. Solhaug MJ, Bolger PM, Jose PA. The developing kidney and environmental toxins. Pediatrics 2004; 113(Suppl): 1084-1091.
39. Robinson JS, Moore VM, Owens JA, McMillen IC. Origins of fetal growth restriction. Eur J Obstet GynecolReprod Biol 2000; 92: 13-19.
40. Anderson GD, Blidner IN, McClemont S, Sinclair JC. Determinants of size at birth in a Canadian population. Am J Obstet Gynecol 1984; 150: 236-244.
41. Pausove Z, Paus T, Sedova L, Berube J. Prenatal exposure to nicotine modifies kidney weight and blood pressure in genetically susceptible rats: a cause of gene-environment interaction. Kidney Int 2003; 64: 829-833.
42. Habek D, Habek JC, Ivanisevic M, Djelmis J. Fetal tobacco syndrome and perinatal outcome. Fetal Diagn Ther 2002; 17: 367-371.
43. Schmidt IM, Chellakooty M, Boisen KA et al. Impaired kidney growth in low birthweight children: distinct effect of maturity and weight for gestational age. Kidney Int 2005; 68: 731-748.
44. Rodriguez MM, Gomez AH, Abitbol CL et al. Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatr Devel Pathol 2004; 7: 17-25.
45. Sayers SM, Powers J. Risk factors for Aboriginal low birthweight, intrauterine growth retardation and preterm birth in the Darwin Health Region. Aust NZ J Public Health 1997; 21: 524-531.
46. Sayers SM, Mackerras D, Singh G et al. An Australian Aboriginal birth cohort: a unique resource for a life course study of an Indigenous population. A study protocol. BMC Int Health Hum Rights 2003; 3: 1.
47. Mackerras D, Sayers S. Birthweights and growth of infants in five Aboriginal communities. Aust NZ J Public Health 2000; 24: 637-639.
48. Singh GR, Sayers SM, Hoy WE. Maternal alcohol ingestion during pregnancy predisposes to albuminuria and smaller kidney in Aboriginal children: Findings in an Aboriginal birth cohort. Nephrology 2004; 9(Suppl 1): P75.
49. Bertram JF, Young RJ, Kincaid Smith P et al. Glomerulomegaly in Australian Aborigines. Nephrology 1998; 4(Siii-Siv): S46-S53.
50. Young RJ, Hoy WE, Kincaid Smith P et al. Glomerular size and glomerulosclerosis in Australian Aborigines. Am J Kidney Dis 2000; 36: 481-489.
51. Barker DJ. Intrauterine programming of adult disease. Mol Med Today 1995; 1: 418-423.
52. Percy C, Pat B, Poronnik P, Gobe G. Role of oxidative stress in age-associated chronic kidney pathologies. Adv Chronic Kidney Dis 2005; 12: 78-83.
53. Brenner BM. Remission of renal disease: recounting the challenge, acquiring the goal. J Clin Invest 2002; 110: 1753-1758.
54. Hoy WE, Wang Z, Baker PRA, Kelly A. Reduction in natural death and renal failure from a systematic screening and treatment program in an Australian Aboriginal community. Kidney Int 2003; 63: S66-S73.
55. Bertram JF. Counting in the kidney. Kidney Int 2001; 59: 792-796.